
Jeffrey Chamberlain, PhD, on Considerations for Exon Skipping and Gene Therapy in DMD
Patients with Duchenne muscular dystrophy (DMD) currently have several advanced therapeutic options for treatment, including several exon skipping therapies and Sarepta Therapeutics' delandistrogene moxeparvovec-rokl (Elevidys), an adeno-associated …